Long-term follow-up after ureteral reimplantation in children: a 12-year analysis

T Gerwinn1,2, M Zellner3,4, A Prouza5,3

  • 1Division of Pediatric Urology, University Children's Hospital Zurich, Zurich, Switzerland. tim.gerwinn@kispi.uzh.ch.

PubMed

Insights

Children with uneventful recoveries after ureteral reimplantation (UR) for high-grade vesicoureteral reflux (VUR) have a low risk of late complications. Routine long-term follow-up may not be necessary for all patients.

Area of Science:

  • Pediatric Urology
  • Nephrology
  • Surgical Outcomes

Background:

  • High-grade vesicoureteral reflux (VUR) and primary obstructed megaureter (POM) in children often require ureteral reimplantation (UR).
  • Long-term outcomes and the necessity of routine follow-up after UR are not fully established.

Purpose of the Study:

  • To evaluate late surgical complications and long-term kidney outcomes after UR for high-grade VUR and POM.
  • To assess the need for routine long-term follow-up in pediatric patients undergoing UR.

Main Methods:

  • Retrospective review of 135 children undergoing UR (2006-2013) with at least 10 years of follow-up.
  • Primary outcomes: postoperative ureterovesical junction obstruction (pUVJO) and febrile urinary tract infections (UTIs).
  • Secondary outcomes: kidney function (BUN/creatinine), renal morphology, and hypertension.

Main Results:

  • 53 renal units in 34 children met criteria. pUVJO occurred in 7.5% (exclusively after Politano-Leadbetter technique, within 8 months).
  • Febrile UTIs occurred in 9 children, mostly within the first postoperative year.
  • One child developed chronic kidney disease; another developed reflux nephropathy without impaired function. No hypertension observed.

Conclusions:

  • Children with uneventful recoveries and no pUVJO in the first year have a low risk of late complications.
  • Routine long-term follow-up may have limited benefit for low-risk patients.
  • Higher-risk groups (Politano-Leadbetter reimplantation, girls, preoperative reflux nephropathy) may benefit from extended follow-up.
Abstract